897 — Wai Yuen Tong Medicine Holdings Cashflow Statement
0.000.00%
- HK$399.41m
- HK$632.60m
- HK$783.88m
- 50
- 65
- 72
- 71
Annual cashflow statement for Wai Yuen Tong Medicine Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 455 | -303 | -47.3 | -5.91 | -13.6 |
Depreciation | |||||
Non-Cash Items | -557 | 397 | 234 | 138 | 307 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -43.5 | 226 | -143 | -76.4 | -213 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -32.5 | 413 | 152 | 168 | 192 |
Capital Expenditures | -6.8 | -59.5 | -26 | -33.4 | -34.6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 432 | -4.99 | 48.2 | 52.7 | -50 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 425 | -64.5 | 22.2 | 19.2 | -84.6 |
Financing Cash Flow Items | -45.1 | -84.4 | -115 | -97 | -158 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -81.6 | -351 | -204 | -159 | -470 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 304 | 31.5 | 2.91 | 16.6 | -372 |